Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 122, Issue , 2016, Pages 62-70

  Ohara, Makoto ^a   Fukui, Tomoyasu ^a   Ouchi, Motoshi ^b   Watanabe, Kentaro ^c   Suzuki, Tatsuya ^d   Yamamoto, Saki ^a   Yamamoto, Takeshi ^a   Hayashi, Toshiyuki ^a   Oba, Kenzo ^e   Hirano, Tsutomu ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e Oarai Coast Core Clinic   (Japan)

Author keywords

Diacron reactive oxygen metabolites; Glucose monitoring; Glucose variability; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N,N DIETHYL 1,4 PHENYLENEDIAMINE; PHENYLENEDIAMINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE DURATION; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; AREA UNDER THE CURVE; BLOOD; GLYCEMIC INDEX; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84994030172     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.09.025     Document Type: Article

References (47)

1. [1] UK Prospective Diabetes Study, (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998), 837–853.
2. [2] Nakagami, T., DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47 (2004), 385–394.
3. [3] Su, G., Mi, S., Tao, H., Li, Z., Yang, H., Zheng, H., Zhou, Y., Ma, C., Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol, 10, 2011, 19.
4. [4] Muqgen, M., Zoppini, G., Bonora, E., Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the verona diabetes study. Diabetes Care 23 (2000), 45–50.
5. [5] Xu, F., Zhao, L.H., Su, J.B., Chen, T., Wang, X.Q., Chen, J.F., Wu, G., Jin, Y., Wang, X.H., The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr, 6, 2014, 139.
6. [6] Sugawara, A., Kawai, K., Motohashi, S., Saito, K., Kodama, S., Yachi, Y., Hirasawa, R., Shimano, H., Yamazaki, K., Sone, H., HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Diabetologia 55 (2012), 2128–2131.
7. [7] Brownlee, M., Hirsch, I.B., Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295 (2006), 1707–1708.
8. 1(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia 54 (2011), 69–72.
9. [9] Siegelaar, S.E., Kerr, L., Jacober, S.J., Devries, J.H., A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study. Diabetes Care 34 (2011), 855–857.
10. [10] Kilpatrick, E.S., Rigby, A.S., Atkin, S.L., A1C variability and the risk of microvascular complications in type 1 diabetes: data from the diabetes control and complications trial. Diabetes Care 31 (2008), 2198–2202.
11. [11] Giugliano, D., Ceriello, A., Paolisso, G., Oxidative stress and diabetic vascular complications. Diabetes Care 19 (1996), 257–267.
12. [12] Brownlee, M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005), 1615–1625.
13. [13] Ceriello, A., Esposito, K., Piconi, L., Ihnat, M.A., Thorpe, J.E., Testa, R., Boemi, M., Giugliano, D., Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57 (2008), 1349–1354.
14. [14] Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., Milzani, A., Biomarkers of oxidative damage in human disease. Clin Chem 52 (2006), 601–623.
15. [15] Chang, C.M., Hsieh, C.J., Huang, J.C., Huang, I.C., Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol 49 (2012), S171–S177.
16. [16] Nakhjavani, M., Ghazizadeh, Z., Nargesi, A.A., Mokhtari, A., Asgarani, F., Imani, M., Davoudi, Z., Esteghamati, A., Prostaglandin F2 alpha plasma concentration predicts glycemic control and oxidation status in patients with type 2 diabetes mellitus. Clin Lab 60 (2014), 2073–2080.
17. [17] Gerardi, G., Usberti, M., Martini, G., Albertini, A., Sugherini, L., Pompella, A., Di Lorenzo, D., Plasma total antioxidant capacity in hemodialyzed patients and its relationship to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 40 (2002), 104–110.
18. [18] Vassalle, C., Boni, C., Di Cecco, P., Landi, P., Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease. Int J Cardiol 110 (2006), 415–416.
19. [19] Vassalle, C., Bianchi, S., Battaglia, D., Landi, P., Bianchi, F., Carpeggiani, C., Elevated levels of oxidative stress as a prognostic predictor of major adverse cardiovascular events in patients with coronary artery disease. J Atheroscler Thromb 19 (2012), 712–717.
20. [20] Ikebuchi, M., Nishio, Y., Maegawa, H., Kashiwagi, A., Effects of hyperglycemia on oxidative stress and antioxidant potential in patients with type 2 diabetes. Diabetol Int 1 (2010), 72–77.
21. [21] Sekhar, R.V., McKay, S.V., Patel, S.G., Guthikonda, A.P., Reddy, V.T., Balasubramanyam, A., Jahoor, F., Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 34 (2011), 162–167.
22. [22] Cockcroft, D.W., Gault, M.H., Prediction of creatinine clearance from serum creatine. Nephron 16 (1976), 31–41.
23. [23] Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., Colette, C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006), 1681–1687.
24. [24] Service, F.J., Molnar, G.D., Rosevear, J.W., Ackermann, E., Gatewood, L.C., Taylor, W.F., Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19 (1970), 644–655.
25. [25] Molnar, G.D., Taylor, W.F., Ho, M.M., Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia 8 (1972), 342–348.
26. [26] Gross, J.L., de Azevedo, M.J., Silveiro, S.P., Canani, L.H., Caramori, M.L., Zelmanovitz, T., Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005), 164–176.
27. [27] Cesarone, M.R., Belcaro, G., Carratelli, M., Cornelli, U., De Sanctis, M.T., Incandela, I., Barsotti, A., Terranova, R., Nicolaides, A., A simple test to monitor oxidative stress. Int Angiol 18 (1999), 127–130.
28. [28] Schnedl, W.J., Lahousen, T., Wallner, S.J., Krause, R., Lipp, R.W., Silent hemoglobin variants and determination of HbA1c with the high resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem 38 (2005), 88–91.
29. [29] Zheng, F., Lu, W., Jia, C., Li, H., Wang, Z., Jia, W., Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine 37 (2010), 201–208.
30. [30] Risso, A., Mercuri, F., Quagliaro, L., Damante, G., Ceriello, A., Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 281 (2001), E924–E930.
31. [31] Azuma, K., Watada, H., Niihashi, M., Otsuka, A., Sato, F., Kawasumi, M., Shimada, S., Tanaka, Y., Kawamori, R., Mitsumata, M., A new En face method is useful to quantitate endothelial damage in vivo. Biochem Biophys Res Commun 309 (2003), 384–390.
32. [32] Azuma, K., Kawamori, R., Toyofuku, Y., Kitahara, Y., Sato, F., Shimizu, T., Miura, K., Mine, T., Tanaka, Y., Mitsumata, M., Watada, H., Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 26 (2006), 2275–2280.
33. [33] Azuma, K., Toyofuku, Y., Iesaki, T., Otsuka, A., Tanaka, A., Mita, T., Hirose, T., Tanaka, Y., Daida, H., Kawamori, R., Watada, H., Acarbose, an a-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 345 (2006), 688–693.
34. [34] Tanaka, A., Azuma, K., Toyofuku, Y., Kurokawa, A., Otsuka, A., Mita, T., Hirosea, T., Fujitani, Y., Miyauchi, K., Daida, H., Kawamori, R., Watada, H., Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 350 (2006), 195–201.
35. [35] Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., Giugliano, D., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002), 2067–2072.
36. [36] Alberti, A., Bolognini, L., Macciantelli, D., Carratelli, M., The radical cation of N, N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem Intermed 26 (2000), 253–267.
37. [37] Monnier, L., Colette, C., Boniface, H., Contribution of postprandial glucose to chronic hyperglycemia: from the ’glucose triad’ to the trilogy of ’sevens’. Diabetes Metab, 32, 2006 2S12–7.
38. [38] Choi, S.W., Benzie, I.F., Lam, C.S., Chat, S.W., Lam, J., Yiu, C.H., Kwan, J.J., Tang, Y.H., Yeung, G.S., Yeung, V.T., Woo, G.C., Hannigan, B.M., Strain, J.J., Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus. Diabet Med 22 (2005), 1347–1353.
39. [39] Piconi, L., Quagliaro, L., Ceriello, A., Oxidative stress in diabetes. Clin Chem Lab Med 41 (2003), 1144–1149.
40. [40] Annadurai, T., Vasanthakumar, A., Geraldine, P., Thomas, P.A., Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus. Diabetes Res Clin Pract 105:1 (2014), 58–69.
41. [41] Cavalot, F., Pagliarino, A., Valle, M., Di Martino, L., Bonomo, K., Massucco, P., Anfossi, G., Trovati, M., Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga. Diabetes Care 34 (2011), 2237–2243.
42. [42] Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003), 486–494.
43. [43] Monnier, L., Colette, C., Rabasa-Lhoret, R., Lapinski, H., Caubel, C., Avignon, A., Boniface, H., Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 25 (2002), 737–741.
44. [44] Zoungas, S., Chalmers, J., Ninomiya, T., Li, Q., Cooper, M.E., Colagiuri, S., et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 55 (2012), 636–643.
45. [45] Wentholt, I.M., Kulik, W., Michels, R.P., Hoekstra, J.B., DeVries, J.H., Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 51 (2008), 183–190.
46. [46] Chen, T., Xu, F., Su, J.B., Wang, X.Q., Chen, J.F., Wu, G., Jin, Y., Wang, X.H., Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance. Diabetol Metab Syndr, 5, 2013, 38.
47. [47] Su, J.B., Chen, T., Xu, F., Wang, X.Q., Chen, J.F., Wu, G., Jin, Y., Wang, X.H., Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels. Endocrine 46 (2014), 241–248.